Holocene Advisors
VINC

Holocene Advisors’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Holocene Advisors’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37,911
Closed -$1.05M – 951
2022
Q3 		$1.05M Hold
37,911
– – 0.01% 610
2022
Q2 		$1M Hold
37,911
– – 0.01% 661
2022
Q1 		$3.03M Hold
37,911
– – 0.02% 390
2021
Q4 		$7.73M Hold
37,911
– – 0.04% 252
2021
Q3 		$12.3M Hold
37,911
– – 0.07% 228
2021
Q2 		$9.85M Buy
37,911
+8,134
+27% +$2.48M 0.06% 232
2021
Q1 		$11.5M Buy
29,777
+11,315
+61% +$4.56M 0.07% 207
2020
Q4 		$7.72M Buy
+18,462
New +$5.82M 0.05% 257

Other funds holding VINC

Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return